Cottrell J E, Casthely P, Brodie J D, Patel K, Klein A, Turndorf H
N Engl J Med. 1978 Apr 13;298(15):809-11. doi: 10.1056/NEJM197804132981502.
To investigate hydroxocobalamin's role in preventing cyanide intoxication from sodium nitroprusside, we studied two groups of patients. One group received nitroprusside alone, and the other received nitroprusside and hydroxocobalamin. Red-cell and plasma cyanide levels were 83.44 +/- 23.12 and 3.51 +/- 1.01 microgram per 100 ml after nitroprusside alone and were 33.18 +/- 17.29 and 2.18 +/- 0.65 microgram per 100 ml after nitroprusside plus hydroxocobalamin. Acidosis developed in patients with red-cell cyanide levels higher than 75 microgram per 100 ml. When hydroxocobalamin infusion was stopped before sodium nitroprusside infusion was discontinued, blood cyanide levels and base deficit increased in a manner similar to that in the untreated group. The dose of nitroprusside used in each group did not differ statistically. These data show that hydroxocobalamin prevents cyanide transfer from red cells and plasma to tissue after nitroprusside metabolism, and thereby prevents cyanide toxicity from large intravenous doses of the drug.
为研究羟钴胺素在预防硝普钠所致氰化物中毒中的作用,我们对两组患者进行了研究。一组仅接受硝普钠治疗,另一组接受硝普钠和羟钴胺素治疗。单独使用硝普钠后,红细胞和血浆中的氰化物水平分别为每100毫升83.44±23.12微克和3.51±1.01微克;使用硝普钠加羟钴胺素后,分别为每100毫升33.18±17.29微克和2.18±0.65微克。红细胞氰化物水平高于每100毫升75微克的患者出现了酸中毒。在硝普钠输注停止前停止羟钴胺素输注时,血氰化物水平和碱缺失的增加方式与未治疗组相似。每组使用的硝普钠剂量在统计学上无差异。这些数据表明,羟钴胺素可防止硝普钠代谢后氰化物从红细胞和血浆转移至组织,从而预防大剂量静脉使用该药物所致的氰化物毒性。